Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
Andrea PlaiknerKathrin SieglerHermann HertelAnna JacobAnja PetzelMelanie SchubertJens-Uwe BlohmerGerd BöhmerSimone MarnitzVolker RagoschChristian DomrösePeter OppeltAnne JülicherAchim SchneiderAnne WillemsGiovanni FaveroChristhardt KöhlerPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Neoadjuvant chemotherapy followed by radical vaginal trachelectomy may be offered to patients seeking motherhood with cervical cancer >2 cm and histopathologically tumor-free lymph nodes, the rate of healthy baby pregnancy on discharge was 10/18 women (55%). This fertility-preserving strategy is associated with higher recurrence and death compared with what was published in the literature for women undergoing radical vaginal trachelectomy for tumors up to 2 cm.
Keyphrases
- patient reported
- neoadjuvant chemotherapy
- lymph node
- sentinel lymph node
- pregnancy outcomes
- locally advanced
- polycystic ovary syndrome
- systematic review
- end stage renal disease
- childhood cancer
- robot assisted
- rectal cancer
- chronic kidney disease
- type diabetes
- prostate cancer
- newly diagnosed
- squamous cell carcinoma
- pregnant women
- preterm birth
- stem cells
- cervical cancer screening
- radiation therapy
- ejection fraction
- prognostic factors
- breast cancer risk
- bone marrow
- cell therapy
- young adults
- skeletal muscle
- weight loss
- free survival
- smoking cessation
- glycemic control